IIL sets up new sterile filling facility in Telangana

 

HYDERABAD, June 24: Indian Immunologicals Ltd

(IIL), a city-based biologicals company, Monday announced the

ground-breaking of a new Sterile Filling Facility (SFF) at its

manufacturing plant in Phase III of Genome Valley, in Ranga

Reddy district, with an investment of Rs 75 crore.

According to a press release issued by IIL, with this

upcoming filling facility, the company expects to increase its

capacity to supply lifesaving vaccines such as the Anti Rabies

Vaccine (ARV) Abhayrab.

The new state-of-the-art facility expected to be ready

later next year.

The sterile filling facility is equipped with hi-end

equipment from the world’s best manufacturers, in line with

the requirements of the nature of work handled at the plant,

it said.

K Anand Kumar, Managing Director of IIL said the

animal health and human health player has a long history of

supplying vaccines critical to public health.

“We are constantly striving to make the vaccines

affordable and accessible to reach the benefits of preventive

healthcare to maximum number of people. The expansion at

Karkapatla plant is in line with our mission and will help

meet the growing requirements of critical vaccines,” he said.

IIL has four manufacturing facilities at various

locations Karkapatla, Telangana Human Vaccines and Animal

Health Formulations; Udhagamadalam, Tamil Nadu Anti Rabies

production unit; Hyderabad, Telangana Human Biologicals Unit

(Gachibowli) and animal vaccines unit; Dargaville, New Zealand

– New Bovine Serum. (PTI)

LEAVE A REPLY

Please enter your comment!
Please enter your name here